WO2006052822A3 - Methods and devices for screening cervical cancer - Google Patents

Methods and devices for screening cervical cancer Download PDF

Info

Publication number
WO2006052822A3
WO2006052822A3 PCT/US2005/040165 US2005040165W WO2006052822A3 WO 2006052822 A3 WO2006052822 A3 WO 2006052822A3 US 2005040165 W US2005040165 W US 2005040165W WO 2006052822 A3 WO2006052822 A3 WO 2006052822A3
Authority
WO
WIPO (PCT)
Prior art keywords
cervical
methods
sample
devices
screening
Prior art date
Application number
PCT/US2005/040165
Other languages
French (fr)
Other versions
WO2006052822A2 (en
Inventor
Urs G Wiederkehr
Jian Ling
Original Assignee
Cytolution Inc
Urs G Wiederkehr
Jian Ling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytolution Inc, Urs G Wiederkehr, Jian Ling filed Critical Cytolution Inc
Priority to US11/718,695 priority Critical patent/US8951746B2/en
Publication of WO2006052822A2 publication Critical patent/WO2006052822A2/en
Publication of WO2006052822A3 publication Critical patent/WO2006052822A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57411Specifically defined cancers of cervix
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The present invention provides multi-parameter analysis methods for determining the presence or absence of precancerous or cancerous cells in a cervical sample and for screening cervical abnormality in a cervical sample. The invention also provides an apparatus and automated methods for screening cervical abnormality in a sample. The invention further provides a sampling device and a sample collection assembly for collecting cell samples, including cervical samples.
PCT/US2005/040165 2004-11-05 2005-11-04 Methods and devices for screening cervical cancer WO2006052822A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/718,695 US8951746B2 (en) 2004-11-05 2005-11-04 Method and devices for screening cervical cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62536904P 2004-11-05 2004-11-05
US60/625,369 2004-11-05

Publications (2)

Publication Number Publication Date
WO2006052822A2 WO2006052822A2 (en) 2006-05-18
WO2006052822A3 true WO2006052822A3 (en) 2007-02-08

Family

ID=36337068

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/040165 WO2006052822A2 (en) 2004-11-05 2005-11-04 Methods and devices for screening cervical cancer

Country Status (2)

Country Link
US (1) US8951746B2 (en)
WO (1) WO2006052822A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107699618B (en) * 2010-11-12 2021-08-20 茵赛德斯有限公司 Method and system for non-disease diagnostic determination of whether Cervical Intraepithelial Neoplasia (CIN) cells are present in a labeled liquid cervical cell sample from a subject

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8131112B1 (en) * 2006-01-23 2012-03-06 Sandia Corporation Method for detecting cancer in a single cell using mitochondrial correlation microscopy
US8105633B2 (en) * 2006-03-01 2012-01-31 Spintec Engineering Gmbh Method and apparatus for extraction of arthropod gland
GB2435646A (en) * 2006-03-01 2007-09-05 Spin Tec Engineering Gmbh Apparatus and method of extraction of an arthropod gland
US20110121485A1 (en) * 2006-10-30 2011-05-26 Spintec Engineering Gmbh Method and apparatus for the manufacture of a fiber
US8355132B2 (en) 2007-04-06 2013-01-15 Qiagen Gaithersburg, Inc. Sample adequacy measurement system having a plurality of sample tubes and using turbidity light scattering techniques
US8703492B2 (en) 2007-04-06 2014-04-22 Qiagen Gaithersburg, Inc. Open platform hybrid manual-automated sample processing system
US8877507B2 (en) 2007-04-06 2014-11-04 Qiagen Gaithersburg, Inc. Ensuring sample adequacy using turbidity light scattering techniques
US8795197B2 (en) * 2007-07-17 2014-08-05 Histologics, LLC Frictional trans-epithelial tissue disruption collection apparatus and method of inducing an immune response
US8652067B2 (en) 2007-07-17 2014-02-18 Histologics, LLC Frictional trans-epithelial tissue disruption and collection apparatus and method of inducing and/or augmenting an immune response
US9399215B2 (en) 2012-04-13 2016-07-26 Bio-Rad Laboratories, Inc. Sample holder with a well having a wicking promoter
US10512910B2 (en) 2008-09-23 2019-12-24 Bio-Rad Laboratories, Inc. Droplet-based analysis method
US9598725B2 (en) 2010-03-02 2017-03-21 Bio-Rad Laboratories, Inc. Emulsion chemistry for encapsulated droplets
US8709762B2 (en) 2010-03-02 2014-04-29 Bio-Rad Laboratories, Inc. System for hot-start amplification via a multiple emulsion
US9492797B2 (en) 2008-09-23 2016-11-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US9764322B2 (en) 2008-09-23 2017-09-19 Bio-Rad Laboratories, Inc. System for generating droplets with pressure monitoring
US9417190B2 (en) 2008-09-23 2016-08-16 Bio-Rad Laboratories, Inc. Calibrations and controls for droplet-based assays
US8951939B2 (en) 2011-07-12 2015-02-10 Bio-Rad Laboratories, Inc. Digital assays with multiplexed detection of two or more targets in the same optical channel
US9132394B2 (en) 2008-09-23 2015-09-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
WO2011120020A1 (en) 2010-03-25 2011-09-29 Quantalife, Inc. Droplet transport system for detection
US9156010B2 (en) 2008-09-23 2015-10-13 Bio-Rad Laboratories, Inc. Droplet-based assay system
US11130128B2 (en) 2008-09-23 2021-09-28 Bio-Rad Laboratories, Inc. Detection method for a target nucleic acid
US8633015B2 (en) 2008-09-23 2014-01-21 Bio-Rad Laboratories, Inc. Flow-based thermocycling system with thermoelectric cooler
WO2011094745A2 (en) * 2010-02-01 2011-08-04 Oasis Diagnostics Corporation Biological sample collection system
WO2011028539A1 (en) 2009-09-02 2011-03-10 Quantalife, Inc. System for mixing fluids by coalescence of multiple emulsions
EP2550351A4 (en) 2010-03-25 2014-07-09 Quantalife Inc Detection system for droplet-based assays
CA2767182C (en) 2010-03-25 2020-03-24 Bio-Rad Laboratories, Inc. Droplet generation for droplet-based assays
DE202011110979U1 (en) 2010-11-01 2017-12-04 Bio-Rad Laboratories, Inc. System for forming emulsions
CA2830443C (en) 2011-03-18 2021-11-16 Bio-Rad Laboratories, Inc. Multiplexed digital assays with combinatorial use of signals
CN103717749A (en) 2011-04-25 2014-04-09 伯乐生命医学产品有限公司 Methods and compositions for nucleic acid analysis
EP2737089B1 (en) 2011-07-29 2017-09-06 Bio-rad Laboratories, Inc. Library characterization by digital assay
US10182796B2 (en) 2012-11-30 2019-01-22 Eve Medical Inc. Specimen collection device and kit
US10201332B1 (en) 2012-12-03 2019-02-12 Healoe Llc Device and method of orienting a biopsy device on epithelial tissue
JP6378599B2 (en) * 2013-10-11 2018-08-22 シスメックス株式会社 Cell analysis method and cell analyzer
JP6629302B2 (en) * 2014-09-17 2020-01-15 ホロジック, インコーポレイテッドHologic, Inc. Separable sample collection device
WO2016075095A2 (en) * 2014-11-10 2016-05-19 Ventana Medical Systems, Inc. Using contextual information to classify nuclei in histology images
CN107771285A (en) 2015-06-08 2018-03-06 阿奎尔诊断有限公司 Method
US11391744B2 (en) 2015-06-08 2022-07-19 Arquer Diagnostic Limited Methods and kits
WO2019021065A2 (en) * 2017-02-13 2019-01-31 Trophodiagnostics, Llc New system and method for collecting, enriching, and isolating trophoblast cells from endocervical canal
US11230729B2 (en) * 2018-04-20 2022-01-25 Inanna Diagnostics, Inc Methods and devices for obtaining cellular and DNA material from human female reproductive system
WO2022064422A1 (en) * 2020-09-24 2022-03-31 Cytosystems Limited Diagnosis of cancer by imaging flow cytometry
WO2023278779A1 (en) * 2021-07-01 2023-01-05 Invenio Imaging, Inc. Systems and methods for preparing, imaging and analyzing cytologic samples

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040002125A1 (en) * 2001-03-30 2004-01-01 Gombrich Peter P. Detection of abnormal cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089416A (en) * 1984-12-24 1992-02-18 Caribbean Microparticles Corporation Method of use of non-fluorescent particles to determine fluorescence threshold of a flow cytometer relative to the autofluorescence of samples
US4852579A (en) 1987-04-20 1989-08-01 Karl Storz Endoscopy Gmbh And Company Photocharacterization and treatment of normal abnormal and ectopic endometrium
US6540981B2 (en) * 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US6405070B1 (en) * 1998-06-16 2002-06-11 Bhaskar Banerjee Detection of cancer using cellular autofluorescence
DE69905832T2 (en) * 1998-09-18 2004-02-05 Massachusetts Institute Of Technology, Cambridge Biological uses of semiconducting nanocrystals
CN1221215C (en) 1999-06-25 2005-10-05 分子诊断学股份有限公司 Personal cervical cell collector
ATE287764T1 (en) * 2000-06-02 2005-02-15 Biocontrol Systems Inc INDEPENDENT DEVICES FOR DETECTING BIOLOGICAL CONTAMINANTS
US6692702B1 (en) * 2000-07-07 2004-02-17 Coulter International Corp. Apparatus for biological sample preparation and analysis
GB0018140D0 (en) * 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (en) 2000-12-18 2002-06-20 Bayer Ag Detecting tumor cells and their precursors in cervical smears, by simultaneous detection of two markers, suitable for automation and providing an objective diagnosis
US20040038320A1 (en) * 2001-03-09 2004-02-26 Bhaskar Banerjee Methods of detecting cancer using cellular autofluorescence
EP1417353A4 (en) * 2001-07-20 2005-08-03 Univ Texas Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin
EP1422526A1 (en) 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
US7598287B2 (en) * 2003-04-01 2009-10-06 Medical College Of Georgia Research Institute, Inc. Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
JP4533382B2 (en) * 2003-08-28 2010-09-01 セルラ・インコーポレイテッド Integrated structure for microfluidic analysis and sorting

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040002125A1 (en) * 2001-03-30 2004-01-01 Gombrich Peter P. Detection of abnormal cells

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107699618B (en) * 2010-11-12 2021-08-20 茵赛德斯有限公司 Method and system for non-disease diagnostic determination of whether Cervical Intraepithelial Neoplasia (CIN) cells are present in a labeled liquid cervical cell sample from a subject

Also Published As

Publication number Publication date
US20080262384A1 (en) 2008-10-23
US8951746B2 (en) 2015-02-10
WO2006052822A2 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
WO2006052822A3 (en) Methods and devices for screening cervical cancer
WO2009075764A3 (en) Methods and apparatus for analyzing samples and collecting sample fractions
WO2005067582A3 (en) Methods and apparatus for enhanced sample identification based on combined analytical techniques
WO2008039946A3 (en) Integrated meter for analyzing biological samples
AU6426099A (en) Collection device for biological samples and methods of use
EP1882950A4 (en) Testing chip for analyzing target substance contained in analyte, and microscopic comprehensive analytical system
WO2001098542A3 (en) Universal collection medium
WO2006004763A3 (en) Apparatus for assaying fluorophores in a capillary
GB2440470B (en) Devices and methods for sample collection and analysis
EP1869159A4 (en) Method and apparatus for automatic cell and biological sample preparation and detection
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
HK1095381A1 (en) Sample collection cup with integrated sample analysis system
WO2009021131A3 (en) System and method for biological sample collection and analyte detection
EP1739402A4 (en) Methods of separating, identifying and dispensing specimen and device therefor, and analyzing device method
IL191053A0 (en) Devices and methods for sample collection and analysis
EP1819283A4 (en) System and method for analyte sampling and analysis with hydrogel
IL177693A0 (en) Method, chip, device and integrated system for detection biological particles
AU2003232726A1 (en) Device for analyzing a test sample and for providing corresponding analysis data
WO2004108959A3 (en) Method and apparatus for spore disruption and/or detection
WO2009086186A3 (en) Automated method and apparatus for detecting erroneous sample collection in clinical assays
ATE365908T1 (en) DEVICE AND METHOD FOR COLLECTING SAMPLES
WO2008048508A3 (en) Prognostic biomarkers in patients with ovarian cancer
AU2003260457A1 (en) A method and kit for the quantitative and/or qualitative detection of components in a sample
WO2006116564A3 (en) Analytical instrumentation, appartuses, and methods
WO2006116018A3 (en) Medical test probe for cell sample collection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase

Ref document number: 05817476

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 11718695

Country of ref document: US